Role of IL-1 in renal ischemic reperfusion injury

Journal of the American Society of Nephrology

Volumn 9, Issue 4, 1998, Pages 614-619

  Haq, Mahmudul ^a,c   Norman, James ^a,c   Saba, Sabiha R ^b,c   Ramirez, German ^a,c   Rabb, Hamid ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOMODULATION; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE INJURY;

EID: 0031944498     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 334: 1448-1460, 1996
2. Braunwald E, Kloner RA: Myocardial reperfusion: A doubled-edged sword? J Clin Invest 76: 1713-1719, 1985
3. Grace PA: Ischemic-reperfusion injury. Br J Surg 81: 637-647, 1994
4. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996
5. Winn RK, Mihelicic D, Vedder NB, Sharar SR, Harlan JM: Monoclonal antibodies to leukocyte and endothelial adhesion molecules attenuate ischemia-reperfusion injury. Behring Inst Mitt 92: 229-237, 1993
6. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR: Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51: 1463-1468, 1997
7. Hellberg PO, Kallskog TO: Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. Kidney Int 36: 555-561, 1989
8. Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 256: F794-F802, 1989
9. Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE: Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol 255: F728-F735, 1988
10. Paller MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 113: 379-386, 1989
11. Thornton MA, Winn R, Alpers CE, Zager RA: An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 135: 509-515, 1989
12. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314, 1994
13. Marks RM, Todd RF, Ward PA: Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 339: 314-317, 1989
14. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91: 812-816, 1994
15. Rabb H, Mendiola CC, Saba SR, Dietz JR, Smith CW, Bonventre JV, Ramirez G: Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 211: 67-73, 1995
16. Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule 1-deficient mice are protected against ischemic injury. J Clin Invest 97: 1056-1063, 1996
17. Springer TA: Adhesion receptors of the immune system. Nature (Lond) 346: 425-434, 1990
18. Rabb H, Ramirez G, Saba SR, Reynolds D, Xu J, Flavell R, Antonia S: Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 271: F408-F413, 1996
19. Arend WP, Joslin FG, Thompson RC, Hannum CH: An IL-1 inhibitor from human monocytes: Production and characterization of biologic properties. J Immunol 143: 1851-1858, 1989
20. Janson RW, King TEJ, Hance KR, Arend WP: Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Respir Dis 148: 495-503, 1993
21. Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98: 38-44, 1992
22. Malyak M, Smith MFJ, Abel AA, Arend WP: Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 14: 20-30, 1993
23. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thomson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (Lond) 343: 336-340, 1990
24. Mazzei GJ, Seckinger PL, Dayer JM, Shaw AR: Purification and characterization of a 26-KDa competitive inhibitor of interleukin-1. Eur J Immunol 20: 683-689, 1990
25. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antagonist binds to the 80-KDa IL-1 receptor but does not initiate IL-I signal transduction. J Biol Chem 266: 10331-10336, 1991
26. Evans MJ, Kaufmann MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981
27. Waldman AS: Targeted homologous recombination in mammalian cells. Crit Rev Oncol Hematol 12: 49-64, 1992
28. Yeung RS, Penninger J, Mak TW: Genetically modified animals and immunodeficiency. Curr Opin Immunol 5: 585-594, 1993
29. Norman JG, Fink G, Franz M, Guffey J, Carter G, Davison B, Sexton C, Glaccum M: Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 223: 163-169, 1996
30. Acton RD, Dahlherg PS, Uknis ME, Klaerner HG, Fink GS, Norman JG, Dunn DL: Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. Arch Surg 131: 1216-1221, 1996
31. Norman JG, Fink GW, Sexton C, Carter G: Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1 beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res 63: 231-236, 1996
32. Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre JV, Ramirez G: Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol 267: F1052-F1058, 1994
33. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M: Induction of interleukin-β mRNA in rat brain after transient forebrain ischemia. J Neurochem 58: 390-392, 1992
34. Coletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA: Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85: 1936-1943, 1990
35. Suzuki S, Toledo-Pereyra LH: Interleukin-1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57: 253-258, 1994
36. Herskowitz A, Choi S, Ansari AA, Wesselingh S: Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146: 419-428, 1995
37. Seekamp A, Mulligan MS, Till GO, Smith CW, Miyasaka M, Tamatani T, Todd RF, Ward PA: Role of β,2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am J Pathol 143: 464-472, 1993
38. Norman JG, Sutton ET, Franz MS, Baker CH: Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of interleukin-1 receptor. Shock 3: 369-375, 1995
39. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, Mukai M, Kitajima M: Interleukin-1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63: 143-148, 1997
40. Norman JG, Franz MG, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117: 648-655, 1995
41. Karolle BL, Weiss SJ, Huber AR, Lim MJ, Buda AJ: The recombinant receptor antagonist to interleukin-1 reduces myocardial neutrophil accumulation and tissue injury following ischemia and reperfusion [Abstract]. Circulation 84(II): 84, 1991
42. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC: Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 221: 625-631, 1995
43. Kelly KJ, Bonventre JV: Protection against ischemic renal injury with blockade of intercellular adhesion molecule-1. In: Acute Renal Failure: New Concepts and Therapeutic Strategies, edited by Goligorsky MES, New York, Churchill Livingstone, 1995, pp 401-424
44. Colotta F, Dower SK, Sims JE, Mantovani A: The type II "decoy" receptor: A novel regulatory pathway for interleukin-1. Immunol Today 15: 562-564, 1994